Five years ago a surprising discovery was made-that certain synthetic preparations, themselves not chemically related to the naturally occurring estrogens, give rise to estrogenic responses when administered to suitable animals.2
say that: (I) given before or after the years of ovarian activity, usually evidenced by menstruation, estrogens bring about striking proliferative changes of the vaginal mucosa, simultaneously producing an acid vaginal secretion; (2) endometrial proliferation to a midinterval stage is observed; (3) sufficient dosage often produces uterine bleeding (menstruation), although this may occur only after the estrogens are discontinued; (4) Hartman and Zuckerman have shown that the phenomenon of menstruation may be postponed in monkeys if the administration of estrin is begun early in the preovulatory part of the menstrual cycle; and (5) in children and in castrates pigmentation of the nipples and mammary growth may be produced by giving a sufficient amount of estrogens over a long enough period of time.
In the different cases mentioned here all of these physiological changes with the exception of (2), were seen after taking stilbestrol orally. Uterine bleeding was taken as evidence that endometrial proliferation had occurred, and it was not thought necessary to curette a patient to prove this point.
Altogether, eight girls have been treated with stilbestrol. To four the drug was given by mouth, while to the remainder it was given in the form of vaginal suppositories, each containing 1 mg. of stilbestrol. All of these patients showed the expected and characteristic vulvar hypertrophy, as well as a proliferation of the vaginal mucosa with the production of acid vaginal "secretions."
Each of three girls was given one pill, containing 5 mg. of stilbestrol, daily for 17 days. At the end of this time the nipples of all of them had changed from the usual pink color to such a dark brown as to be almost black. One child showed a very slight breast enlargement, which disappeared after stopping the drug. One 10-year-old child received 1 mg. of stilbestrol daily for 21 days. In this case bronzing of the nipples and a moderate hypertrophy of the breasts were produced, in addition to the usual vaginal changes.
Speaking very generally, patients suffering with menopausal symptoms fall into two major classes:-1) Those suffering almost entirely from vasomotor disturbances, including hot flashes, headache (usually frontal), and a peculiar type of vertigo.
2) Those in whom these symptoms are subordinate; who present what we may call evidences of nervous or psychic disorder.
I believe that the majority of the former group can be relieved if sufficient estrogens are given. The latter group yield unsatisfactory results to estrogenic therapy.
Unlike Shorre and Papanikalaoun, it is our belief that to relieve vasomotor symptoms one must often give more estrogens than are needed to produce vaginal changes. In all likelihood insufficient dosage has often accounted for failure in these cases.
Ten women with typical vasomotor menopausal disturbances were treated (office patients). They were chosen as having few accompanying nervous symptoms. While Parkes and Dodds report three of fifty-one patients unable to take stilbestrol because of vomiting, I was less successful in that two of the ten became nauseated and were unable to continue taking the drug. Of the remaining eight patients, six obtained complete relief from their hot flashes, while the accompanying headache and dizziness improved or were entirely cured. One patient was entirely relieved for three months, but has just reported nausea. One was not benefited.
In some of the cases treated, relief was astonishingly prompt. As a rule, before beginning treatment I have had patients with menopausal disturbances keep a chart for a week, checking each 24 hours the number of times that they experienced the so-called hot flashes as they occur, and specifying each time whether the symptom was mild, moderate, or severe. A further note is made at the end of the day on the presence or absence of headache and vertigo. This helps in determining the severity of symptoms in any given case, and helps both patient and physician to decide how much or how little benefit is conferred by any given treatment.
The case of Mrs. Z, aet. 42, illustrates the results which may be hoped for. On Dec. 1, 1938, I removed her uterus, tubes, and ovaries. Recovery was uneventful and the patient returned to her home in two weeks. Early in January she again took to her bed, stating that headache and dizziness made it impossible for her to be comfortable if she moved about. "Hot flashes" disturbed her day and night. Her chart at the week's end showed that she averaged thirty "hot flashes" each 24 hours, that headache was constant during the day, and that dizziness was frequent. Phenobarbital and other sedatives were given without benefit.
On March 1 she was instructed to take one pill containing 5 mg. of stilbestrol daily by mouth. Three days later improvement was marked. "Hot flashes" were no longer experienced. Headache and vertigo were absent by the end of the week. The dose of stilbestrol was soon reduced to 2 mg., alternating with 1 mg. daily. During subsequent months the patient has remained symptomless except when pills were purposely omitted several times. On each of these occasions the disturbing symptoms returned within three days. It is important to note that in her case stilbestrol, though given freely, caused no nausea or vomiting at any time.
In the other cases, the results, while not as spectacular, were equally satisfactory. Two of the patients treated for menopausal vasomotor disturbances also showed atrophy of the vaginal mucosa with a nearly neutral reaction of the vaginal secretions. After three weeks' treatment with stilbestrol, squamous cell proliferation and normal vaginal acidity were present.
Two women, well past the menopause, had uterine (menstrual) bleeding while under treatment. One of them has had three periods of bleeding, though not at regular intervals.
Three other patients with senile vaginitis and vulvar atrophy were not much, if at all, benefited symptomatically by taking stilbestrol, although hypertrophy of the vaginal mucosa was brought about by the treatment.
Conclusions The physiological response of women treated with the synthetic drug stilbestrol appears to be the same as that elicited by the administration of the natural estrogens.
The cost of manufacturing stilbestrol is less than is the cost of preparing the natural estrogens.
The fact that stilbestrol is effective when given orally is advantageous.
Stilbestrol may produce nausea and even vomiting in some cases, contraindicating its further use.
It is suggested that patients, when given this or any other estrogen, be also given periods of several weeks' rest from the drug at intervals. There are possible risks in long-continued uninterrupted stimulation of the genital tract and breasts.
It should be emphasized that this paper makes no attempt at a statistical statement of results. For example, a number of patients with menopausal disturbances other than vasomotor have been treated with less success than those in the carefully selected group mentioned. There is reason to believe, also, that nausea and vomiting result more often than this paper would suggest. BIBLIOGRAPHY 1 Bishop, Boycott, and Zuckerman: Lancet, 1939 , i, 5-11. 2 Dodds: Lancet, 1934 , i, 987. 3 Dodds, Lauson, and Noble: Lancet, 1938 , i, 1389 -90. 4-Loeser: Brit. Med. J., 1939 , i, 13. S Winterton: Brit. Med. J., 1939 The stilbestrol used in the treatment of these cases was made and supplied free by E. R. Squibb & Co.
